Firstly, it was shown that as IDH-mutant glioma cells tend to export R-2-HG to protect themselves from its toxic effects, the extracellular concentration of R-2-HG is found to be five-fold higher than the intracellular concentration [87,90]. The gene discussed is IDH1; the disease is glioma.